Page 1

a Abbott TOTAL COMPANY $ 10.2B TOTAL COMPANY SALES WORLDWIDE $ 1.17 ADJUSTED DILUTED EPS² TO KEY BUSINESS UNITS5 ON AN ORGANIC BASIS * S + 45.1 % MEDICAL DEVICES + 35 % ¹ FULL - YEAR 2021 GUIDANCE REMAINS UNCHANGED ADJUSTED DILUTED EPS4 $ 4.30 + 9.5 % NUTRITION ON AN ORGANIC BASIS * REFLECTS OVER 105 % ³ GROWTH VERSUS THE PRIOR YEAR REFLECTS STRONG DOUBLE - DIGIT GROWTH $ 4.50 + 57.2 % DIAGNOSTICS + 14.5 % ESTABLISHED PHARMACEUTICALS BUSINESS HIGHLIGHTS A SECOND - QUARTER 2021 RESULTS ▶ FREESTYLE LIBREⓇ + 43 % growth in FreeStyle Libre O on - an organic basis ▸ World's leading ' continuous glucose monitoring system has nearly 3.5 millio users worldwide NUTRITION 16 % growth in Adult Nutrition on an organic basis ▸ Pandemic continues to raise awareness of how good nutrition and hydration support immune health DIAGNOSTICS 57 % growth on an organic basis ▸ Partnership with United Airlines enables international travelers to use BinaxNOW ™ ‡ Home Test and NAVICA ™ app to return to the U.S. if they test negative 112 2AM 6 Ensure MAX PROTEIN Nutrition Shake 309C % LESS SUGAR Protein 150 1g Sugar CAFFEINE RUGE MOTHE PASSPORT 22 COMID - 19 Ag Card HOME TEST dan the number * Organic sales growth exclude impact of foreign exchange . For full financial data and reconciliation of non - GAAP mamures , plane see our press release dated July 22 , 2021 , available at www.abbottinestar.com 1.Ona GAAP basis , cond - quarter Abbott sales increased 39.5 % 2. Second - quarter GAAP diluted EPS was $ 0.66 3. Second - quarter diluted EPS from continuing operations on a GAAP basis reflects 120 % growth . 4. Abbott projects 2021 diluted warnings per share from continuing operations under GAAP of $ 2.75 to $ 2.95 . Abbott forecasts specified items for the full - year 2021 of $ 155 per share primarily related to intangible amortization , restructuring and cost reduction initiatives , including experes to dign its COVID - 19 timing - related busines with current and projected demand , experes asociated with acquaisions and other net expenses . 5. Ona GAAP bais , Medical Devices sales incremed 513 % Diagnostics salan increased 62.8 % ; Nutrition salesincramed II 16.4 % Ona GAAP Data on file , Abbott Diabet C Care on the number of users worldwide ■ for the FreeStyle Libre system of users for other leading personal use , sensor - based glucose monitoring systems . & Ona GAAP basis , Global Adult Nutrition increased 18 % 9.Ona GAAP basis , Diagnostics incremed 63 % + Find important safety information about the FreeStyle® Libre portfolio : sww.fremtylelibra.vahabaty - information . The BinaxNOW COVID - 19 Ag Card Home Tent is a lateral flow immuncs may intended for the qualitative detection of nudeccapaid protein antigen from SARS - CoV - 2 . This test is authorised for prescription home use with self - collected observed direct anterior nasal ( nares ) swab samples from individuals aged 15 years or dider who are suspected of COVID - 19 by their healthcare provider within the first seven days of symptom anset or adult collected nasal swab samples from individuals aged four years or dider who are suspected of COVID - 19 by their healthcare provider within the first seven days of symptom onset . The BinaxNOW COVID - 19 Ag Card Home Tent is to be performed only with the supervision of a tal health practor . FORWARD - LOOKING STATEMENTS Some statements in this neva relame may be forward - looking statements for purposes of the Private Securition Litigation Reform Act of 1995. Abbott cautions that these forward - looking statements are subject to risks and uncertaines that may cause actual results to differ materially from those indicated in the forward - looking statements Economic , competitiva , govemmental , technological and other factors that may affect Abbott's operations are discussed in Item 1A , " Risk Factors in our Annual Report on Form 10 - K for the year anded Dec. 31 , 2020 , and are incorporated herein by reference . Abbott undertaken no obligation to relama publidy any revisions to forward - looking statements as a result of subsequent events or developments , except as required by law . GISES